Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-08

Clinical Trial Update: Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of dapagliflozin and saxagliptin added to metformin versus saxagliptin or dapagliflozin alone in type 2 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)
  • Saxagliptin (saxagliptin)
  • metformin (metformin)

Snippet

Sponsor: University of Pisa | Conditions: Type2 Diabetes Mellitus | Phase 2 | Status: COMPLETED